In this report, FX11, a known direct competitive inhibitor of murine LDHA, ameliorated disease pathology, restricted mycobacterial growth and potentiated the bactericidal effect of INH, a frontline anti-TB drug. The gene discussed is LDHA; the disease is tuberculosis.